Clinical trial NCT03537872 - References

HIV — PROvide MIner-friendly SErvices for Integrated TB/HIV Care in Lesotho Study

Citation(s)

•   Abdissa HG, Lemu YK, Nigussie DT
  HIV preventive behavior and associated factors among mining workers in Sali traditional gold mining site Bench Maji zone, Southwest Ethiopia: a cross sectional study. BMC Public Health. 2014 Sep 26;14:1003. doi: 10.1186/1471-2458-14-1003.
•   Baleta A
  Southern African declaration targets TB in mining sector. Lancet. 2012 Oct 6;380(9849):1217-8. doi: 10.1016/s0140-6736(12)61698-5. No abstract available.
•   Barnighausen T, Chaiyachati K, Chimbindi N, Peoples A, Haberer J, Newell ML
  Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. Lancet Infect Dis. 2011 Dec;11(12):942-51. doi: 10.1016/S1473-3099(11)70181-5. Epub 2011 Oct 24.
•   Barwise K, Lind A, Bennett R, Martins E
  Intensifying action to address HIV and tuberculosis in Mozambique's cross-border mining sector. Int J Health Serv. 2013;43(4):699-719. doi: 10.2190/HS.43.4.g.
•   Basu S, Stuckler D, Gonsalves G, Lurie M
  The production of consumption: addressing the impact of mineral mining on tuberculosis in southern Africa. Global Health. 2009 Sep 29;5:11. doi: 10.1186/1744-8603-5-11.
•   Brock DM, Sarason IG, Sarason BR, Pierce GR
  Simultaneous assessment of perceived global and relationship-specific support. Journal of Social and Personal Relationships 1996;13:143-152.
•   Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA
  The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med. 1998 Sep 14;158(16):1789-95. doi: 10.1001/archinte.158.16.1789.
•   Bygrave H, Kranzer K, Hilderbrand K, Whittall J, Jouquet G, Goemaere E, Vlahakis N, Trivino L, Makakole L, Ford N
  Trends in loss to follow-up among migrant workers on antiretroviral therapy in a community cohort in Lesotho. PLoS One. 2010 Oct 8;5(10):e13198. doi: 10.1371/journal.pone.0013198.
•   Campbell C
  Migrancy, masculine identities and AIDS: the psychosocial context of HIV transmission on the South African gold mines. Soc Sci Med. 1997 Jul;45(2):273-81. doi: 10.1016/s0277-9536(96)00343-7.
•   Chaisson RE, Barnes GL, Hackman J, Watkinson L, Kimbrough L, Metha S, Cavalcante S, Moore RD
  A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users. Am J Med. 2001 Jun 1;110(8):610-5. doi: 10.1016/s0002-9343(01)00695-7.
•   Charalambous S, Grant AD, Innes C, Hoffmann CJ, Dowdeswell R, Pienaar J, Fielding KL, Churchyard GJ
  Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme. AIDS. 2010 Nov;24 Suppl 5(0 5):S5-13. doi: 10.1097/01.aids.0000391010.02774.6f.
•   Clinton Health Access Initiative
  Health Findings and Recommendations: Domestic and Cross-Border Miners in Lesotho. Maseru; 2015.
•   Corbett EL, Churchyard GJ, Clayton TC, Williams BG, Mulder D, Hayes RJ, De Cock KM
  HIV infection and silicosis: the impact of two potent risk factors on the incidence of mycobacterial disease in South African miners. AIDS. 2000 Dec 1;14(17):2759-68. doi: 10.1097/00002030-200012010-00016.
•   Corbett EL, Marston B, Churchyard GJ, De Cock KM
  Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet. 2006 Mar 18;367(9514):926-37. doi: 10.1016/S0140-6736(06)68383-9.
•   Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C
  The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003 May 12;163(9):1009-21. doi: 10.1001/archinte.163.9.1009.
•   Corbin J, Strauss A
  Grounded theory research: Procedures, canons, and evaluative criteria. Qualitative Sociology 1990;13:3-21.
•   Corno L, de Walque D
  Mines, migration and HIV/AIDS in southern Africa. J of African Economies 2012;21(3):465-498.
•   Currie CS, Williams BG, Cheng RC, Dye C
  Tuberculosis epidemics driven by HIV: is prevention better than cure? AIDS. 2003 Nov 21;17(17):2501-8. doi: 10.1097/01.aids.0000096903.73209.ac.
•   Dahab M, Charalambous S, Hamilton R, Fielding K, Kielmann K, Churchyard GJ, Grant AD
  "That is why I stopped the ART": patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme. BMC Public Health. 2008 Feb 18;8:63. doi: 10.1186/1471-2458-8-63.
•   DiCarlo AL, Mantell JE, Remien RH, Zerbe A, Morris D, Pitt B, Abrams EJ, El-Sadr WM
  'Men usually say that HIV testing is for women': gender dynamics and perceptions of HIV testing in Lesotho. Cult Health Sex. 2014;16(8):867-82. doi: 10.1080/13691058.2014.913812. Epub 2014 May 22.
•   Diero L, Carter EJ, Silka A, Kimaiyo S, Gardner A, Yiannoutsos C, et al
  The experience and outcomes of isoniazid preventive therapy in an HIV treatment program in Western Kenya. XVII International AIDS Conference 2008. Mexico City. Abstract MOAB0306; 2008.
•   Dunkle KL, Jewkes RK, Brown HC, Yoshihama M, Gray GE, McIntyre JA, Harlow SD
  Prevalence and patterns of gender-based violence and revictimization among women attending antenatal clinics in Soweto, South Africa. Am J Epidemiol. 2004 Aug 1;160(3):230-9. doi: 10.1093/aje/kwh194.
•   Durovni B, Cavalcante SC, Saraceni V, Vellozo V, Israel G, King BS, Cohn S, Efron A, Pacheco AG, Moulton LH, Chaisson RE, Golub JE
  The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study. AIDS. 2010 Nov;24 Suppl 5(Suppl 5):S49-56. doi: 10.1097/01.aids.0000391022.95412.a6.
•   Durovni B, Saraceni V, Moulton LH, Pacheco AG, Cavalcante SC, King BS, Cohn S, Efron A, Chaisson RE, Golub JE
  Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial. Lancet Infect Dis. 2013 Oct;13(10):852-8. doi: 10.1016/S1473-3099(13)70187-7. Epub 2013 Aug 16.
•   El Sadr W, Branson B, Hall HI, Beauchamp G, Donnell D, Torian L, et al
  Effect of financial incentives on linkage to care and viral suppression: HPTN 065 (TLC-Plus) Study. Conference on Retroviruses and Opportunistic Infections 23-26 February 2015. Seattle. Abstract 29.
•   Emenyonu N MW, Habyarimana J, Pops-Eleches C, Thirumurthy H, Ragland K, Bangsberg DR
  Cash transfers to cover clinic transportation costs improve retention in care in a HIV treatment program in rural Uganda. 17th Conference on Retroviruses and Opportunistic Infections 16-19 February 2010. San Francisco. Abstract 831.
•   Etienne M, Burrows L, Osotimehin B, Macharia T, Hossain B, Redfield RR, Amoroso A
  Situational analysis of varying models of adherence support and loss to follow up rates; findings from 27 treatment facilities in eight resource limited countries. Trop Med Int Health. 2010 Jun;15 Suppl 1:76-81. doi: 10.1111/j.1365-3156.2010.02513.x.
•   Fielding KL, Grant AD, Hayes RJ, Chaisson RE, Corbett EL, Churchyard GJ
  Thibela TB: design and methods of a cluster randomised trial of the effect of community-wide isoniazid preventive therapy on tuberculosis amongst gold miners in South Africa. Contemp Clin Trials. 2011 May;32(3):382-92. doi: 10.1016/j.cct.2010.12.008. Epub 2010 Dec 28.
•   Getahun H, Gunneberg C, Granich R, Nunn P
  HIV infection-associated tuberculosis: the epidemiology and the response. Clin Infect Dis. 2010 May 15;50 Suppl 3:S201-7. doi: 10.1086/651492.
•   Gilbert JA, Long EF, Brooks RP, Friedland GH, Moll AP, Townsend JP, Galvani AP, Shenoi SV
  Integrating Community-Based Interventions to Reverse the Convergent TB/HIV Epidemics in Rural South Africa. PLoS One. 2015 May 4;10(5):e0126267. doi: 10.1371/journal.pone.0126267. eCollection 2015.
•   Global tuberculosis report 2016
  Geneva, Switzerland: World Health Organization; 2016.
•   Golub JE, Pronyk P, Mohapi L, Thsabangu N, Moshabela M, Struthers H, Gray GE, McIntyre JA, Chaisson RE, Martinson NA
  Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. AIDS. 2009 Mar 13;23(5):631-6. doi: 10.1097/QAD.0b013e328327964f.
•   Golub JE, Saraceni V, Cavalcante SC, Pacheco AG, Moulton LH, King BS, Efron A, Moore RD, Chaisson RE, Durovni B
  The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. AIDS. 2007 Jul 11;21(11):1441-8. doi: 10.1097/QAD.0b013e328216f441.
•   Govender K, Akintola O, George G, Petersen I, Bhagwanjee A, Reardon C
  Psychosocial and behavioural correlates of attitudes towards antiretroviral therapy (ART) in a sample of South African mineworkers. SAHARA J. 2011;8(2):55-64. doi: 10.1080/17290376.2011.9724986.
•   Group GGATSC
  Tobacco Questions for Surveys: A Subset of Key Questions from the Global Adult Tobacco Survey (GATS), 2nd Edition. Atlanta, GA: Centers for Disease Control and Prevention; 2011.
•   Guerra RL, Conde MB, Efron A, Loredo C, Bastos G, Chaisson RE, Golub JE
  Point-of-care Arkansas method for measuring adherence to treatment with isoniazid. Respir Med. 2010 May;104(5):754-7. doi: 10.1016/j.rmed.2010.02.001. Epub 2010 Mar 3.
•   Gupta A, Wood R, Kaplan R, Bekker LG, Lawn SD
  Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community. PLoS One. 2012;7(3):e34156. doi: 10.1371/journal.pone.0034156. Epub 2012 Mar 30.
•   Howard AA, Hirsch-Moverman Y, Frederix K, Daftary A, Saito S, Gross T, Wu Y, Maama LB
  The START Study to evaluate the effectiveness of a combination intervention package to enhance antiretroviral therapy uptake and retention during TB treatment among TB/HIV patients in Lesotho: rationale and design of a mixed-methods, cluster-randomized trial. Glob Health Action. 2016 Jun 27;9:31543. doi: 10.3402/gha.v9.31543. eCollection 2016.
•   Howard AA, Hirsch-Moverman Y, Saito S, Gadisa T, Daftary A, Melaku Z
  The ENRICH Study to evaluate the effectiveness of a combination intervention package to improve isoniazid preventive therapy initiation, adherence and completion among people living with HIV in Ethiopia: rationale and design of a mixed methods cluster randomized trial. Contemp Clin Trials Commun. 2017 Jun;6:46-54. doi: 10.1016/j.conctc.2017.03.001. Epub 2017 Mar 16.
•   Howard AA, Saito S, Frederix K, Hirsch-Moverman Y, Maama LB, Tau P, et al
  Integrating TB/HIV Services for Migrant Miners and Their Families in Lesotho. Conference on Retroviruses and Opportunistic Infections February 22-25, 2016. Boston. Abstract 738.
•   INSIGHT START Study Group; Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, Avihingsanon A, Cooper DA, Fatkenheuer G, Llibre JM, Molina JM, Munderi P, Schechter M, Wood R, Klingman KL, Collins S, Lane HC, Phillips AN, Neaton JD
  Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med. 2015 Aug 27;373(9):795-807. doi: 10.1056/NEJMoa1506816. Epub 2015 Jul 20.
•   International Organization for Migration
  Country assessment on HIV prevention needs of migrants and mobile populations: Lesotho. Pretoria; 2010.
•   IsoScreen
  Oxfordshire, UK: GFC Diagnostic Ltd.
•   Joint United Nations Programme on HIV/AIDS (UNAIDS)
  90-90-90 An ambitious treatment target to help end the AIDS epidemic. http://www.unaids.org/sites/default/files/media_asset/90-90-90_en_0.pdf; Accessed March 22, 2016.
•   Joint United States Programme on HIV/AIDS (UNAIDS)
  The GAP Report. Geneva; 2014. http://www.unaids.org/sites/default/files/media_asset/UNAIDS_Gap_report_en.pdf. Accessed Jul 18, 2015.
•   Kalichman SC, Simbayi LC, Jooste S, Toefy Y, Cain D, Cherry C, Kagee A
  Development of a brief scale to measure AIDS-related stigma in South Africa. AIDS Behav. 2005 Jun;9(2):135-43. doi: 10.1007/s10461-005-3895-x.
•   Kranzer K, van Schaik N, Karmue U, Middelkoop K, Sebastian E, Lawn SD, Wood R, Bekker LG
  High prevalence of self-reported undiagnosed HIV despite high coverage of HIV testing: a cross-sectional population based sero-survey in South Africa. PLoS One. 2011;6(9):e25244. doi: 10.1371/journal.pone.0025244. Epub 2011 Sep 28.
•   Kroenke K, Spitzer RL, Williams JB
  The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x.
•   Lesotho Ministry of Health, ICF International
  Lesotho Demographic and Health Survey 2014. Key Indicators Report. Maseru; 2015.
•   Lesotho Ministry of Health
  A situation analysis of miners and ex-miners affected and infected by tuberculosis: Lesotho. Maseru; 2012.
•   Lesotho Ministry of Health
  Global AIDS response progress report 2015: Lesotho country report. Reporting period January-December 2014. Maseru; 2015.
•   Lesotho National TB Programme
  Maseru; 2013.
•   Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, Jack W, Habyarimana J, Sadatsafavi M, Najafzadeh M, Marra CA, Estambale B, Ngugi E, Ball TB, Thabane L, Gelmon LJ, Kimani J, Ackers M, Plummer FA
  Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. 2010 Nov 27;376(9755):1838-45. doi: 10.1016/S0140-6736(10)61997-6. Epub 2010 Nov 9.
•   Lubogo D, Ddamulira JB, Tweheyo R, Wamani H
  Factors associated with access to HIV care services in eastern Uganda: the Kumi home based HIV counseling and testing program experience. BMC Fam Pract. 2015 Nov 3;16:162. doi: 10.1186/s12875-015-0379-6.
•   Martins-Fonteyn E, Loquiha O, Wouters E, Raimundo I, Hens N, Aerts M, Meulemans H
  HIV Susceptibility Among Migrant Miners in Chokwe: A Case Study. Int J Health Serv. 2016 Oct;46(4):712-33. doi: 10.1177/0020731415585988. Epub 2015 May 19.
•   Mkopi A, Range N, Lwilla F, Egwaga S, Schulze A, Geubbels E, van Leth F
  Adherence to tuberculosis therapy among patients receiving home-based directly observed treatment: evidence from the United Republic of Tanzania. PLoS One. 2012;7(12):e51828. doi: 10.1371/journal.pone.0051828. Epub 2012 Dec 19.
•   Murray J, Davies T, Rees D
  Occupational lung disease in the South African mining industry: research and policy implementation. J Public Health Policy. 2011;32 Suppl 1:S65-79. doi: 10.1057/jphp.2011.25.
•   Nyamathi AM, Christiani A, Nahid P, Gregerson P, Leake B
  A randomized controlled trial of two treatment programs for homeless adults with latent tuberculosis infection. Int J Tuberc Lung Dis. 2006 Jul;10(7):775-82.
•   Pathways to Engagement in HIV-Care for Newly Diagnosed South Africans, R01-MH83561, 2009-2014, Susie Hoffman DrPH, PI
  
•   Patton MW
  Developing a time motion study for a lean healthcare environment: University of Kentucky; 2011.
•   PEPFAR Scientific Advisory Board (SAB)
  Recommendations Regarding Provision of ART for all Persons Living with HIV ("Test and START"). http://www.pepfar.gov/documents/organization/250048.pdf. Accessed March 21, 2016.
•   Pop-Eleches C, Thirumurthy H, Habyarimana JP, Zivin JG, Goldstein MP, de Walque D, MacKeen L, Haberer J, Kimaiyo S, Sidle J, Ngare D, Bangsberg DR
  Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS. 2011 Mar 27;25(6):825-34. doi: 10.1097/QAD.0b013e32834380c1.
•   Rees D, Murray J, Nelson G, Sonnenberg P
  Oscillating migration and the epidemics of silicosis, tuberculosis, and HIV infection in South African gold miners. Am J Ind Med. 2010 Apr;53(4):398-404. doi: 10.1002/ajim.20716.
•   Sabapathy K, Van den Bergh R, Fidler S, Hayes R, Ford N
  Uptake of home-based voluntary HIV testing in sub-Saharan Africa: a systematic review and meta-analysis. PLoS Med. 2012;9(12):e1001351. doi: 10.1371/journal.pmed.1001351. Epub 2012 Dec 4.
•   Samandari T, Agizew TB, Nyirenda S, Tedla Z, Sibanda T, Shang N, Mosimaneotsile B, Motsamai OI, Bozeman L, Davis MK, Talbot EA, Moeti TL, Moffat HJ, Kilmarx PH, Castro KG, Wells CD
  6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. Lancet. 2011 May 7;377(9777):1588-98. doi: 10.1016/S0140-6736(11)60204-3. Epub 2011 Apr 12.
•   Shanaube K, Chaila JM, Floyd S, Schaap A, Griffith S, Hayes R, et al
  Uptake of HIV Testing in the HPTN 071 (PopART) Trial in Zambia. Conference on Retroviruses and Opportunistic Infections February 22-25, 2016. Boston. Abstract 981.
•   Siu GE, Wight D, Seeley J
  How a masculine work ethic and economic circumstances affect uptake of HIV treatment: experiences of men from an artisanal gold mining community in rural eastern Uganda. J Int AIDS Soc. 2012 Jun 14;15 Suppl 1(Suppl 1):1-9. doi: 10.7448/IAS.15.3.17368.
•   South African Development Community
  Declaration on Tuberculosis in the Mining Sector. Maputo; 2012.
•   South African Development Community
  Policy framework for population mobillity and communicable diseases in the SADC region. Gaborone; 2009.
•   Steele S
  Human trafficking, labor brokering, and mining in southern Africa: responding to a decentralized and hidden public health disaster. Int J Health Serv. 2013;43(4):665-80. doi: 10.2190/HS.43.4.e.
•   Stuckler D, Basu S, McKee M, Lurie M
  Mining and risk of tuberculosis in sub-Saharan Africa. Am J Public Health. 2011 Mar;101(3):524-30. doi: 10.2105/AJPH.2009.175646. Epub 2010 Jun 1.
•   Stuckler D, Steele S, Lurie M, Basu S
  Introduction: 'dying for gold': the effects of mineral miningon HIV, tuberculosis, silicosis, and occupational diseases in southern Africa. Int J Health Serv. 2013;43(4):639-49. doi: 10.2190/HS.43.4.c.
•   Suphanchaimat R, Sommanustweechai A, Khitdee C, Thaichinda C, Kantamaturapoj K, Leelahavarong P, Jumriangrit P, Topothai T, Wisaijohn T, Putthasri W
  HIV/AIDS health care challenges for cross-country migrants in low- and middle-income countries: a scoping review. HIV AIDS (Auckl). 2014 Feb 26;6:19-38. doi: 10.2147/HIV.S56277. eCollection 2014.
•   Tavitian SM, Spalek VH, Bailey RP
  A pharmacist-managed clinic for treatment of latent tuberculosis infection in health care workers. Am J Health Syst Pharm. 2003 Sep 15;60(18):1856-61. doi: 10.1093/ajhp/60.18.1856.
•   TEMPRANO ANRS 12136 Study Group; Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, Ouassa T, Ouattara E, Anzian A, Ntakpe JB, Minga A, Kouame GM, Bouhoussou F, Emieme A, Kouame A, Inwoley A, Toni TD, Ahiboh H, Kabran M, Rabe C, Sidibe B, Nzunetu G, Konan R, Gnokoro J, Gouesse P, Messou E, Dohoun L, Kamagate S, Yao A, Amon S, Kouame AB, Koua A, Kouame E, Ndri Y, Ba-Gomis O, Daligou M, Ackoundze S, Hawerlander D, Ani A, Dembele F, Kone F, Guehi C, Kanga C, Koule S, Seri J, Oyebi M, Mbakop N, Makaila O, Babatunde C, Babatounde N, Bleoue G, Tchoutedjem M, Kouadio AC, Sena G, Yededji SY, Assi R, Bakayoko A, Mahassadi A, Attia A, Oussou A, Mobio M, Bamba D, Koman M, Horo A, Deschamps N, Chenal H, Sassan-Morokro M, Konate S, Aka K, Aoussi E, Journot V, Nchot C, Karcher S, Chaix ML, Rouzioux C, Sow PS, Perronne C, Girard PM, Menan H, Bissagnene E, Kadio A, Ettiegne-Traore V, Moh-Semde C, Kouame A, Massumbuko JM, Chene G, Dosso M, Domoua SK, N'Dri-Yoman T, Salamon R, Eholie SP, Anglaret X
  A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. N Engl J Med. 2015 Aug 27;373(9):808-22. doi: 10.1056/NEJMoa1507198. Epub 2015 Jul 20.
•   Tulsky JP, Pilote L, Hahn JA, Zolopa AJ, Burke M, Chesney M, Moss AR
  Adherence to isoniazid prophylaxis in the homeless: a randomized controlled trial. Arch Intern Med. 2000 Mar 13;160(5):697-702. doi: 10.1001/archinte.160.5.697.
•   van den Boogaard J, Lyimo RA, Boeree MJ, Kibiki GS, Aarnoutse RE
  Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot study. Bull World Health Organ. 2011 Sep 1;89(9):632-9. doi: 10.2471/BLT.11.086462. Epub 2011 May 20.
•   Vynnycky E, Sumner T, Fielding KL, Lewis JJ, Cox AP, Hayes RJ, Corbett EL, Churchyard GJ, Grant AD, White RG
  Tuberculosis control in South African gold mines: mathematical modeling of a trial of community-wide isoniazid preventive therapy. Am J Epidemiol. 2015 Apr 15;181(8):619-32. doi: 10.1093/aje/kwu320. Epub 2015 Mar 19.
•   White MC, Tulsky JP, Goldenson J, Portillo CJ, Kawamura M, Menendez E
  Randomized controlled trial of interventions to improve follow-up for latent tuberculosis infection after release from jail. Arch Intern Med. 2002 May 13;162(9):1044-50. doi: 10.1001/archinte.162.9.1044.
•   White MC, Tulsky JP, Menendez E, Arai S, Goldenson J, Kawamura LM
  Improving tuberculosis therapy completion after jail: translation of research to practice. Health Educ Res. 2005 Apr;20(2):163-74. doi: 10.1093/her/cyg109. Epub 2004 Aug 16.
•   White MC, Tulsky JP, Menendez E, Goldenson J, Kawamura LM
  Incidence of TB in inmates with latent TB infection: 5-year follow-up. Am J Prev Med. 2005 Nov;29(4):295-301. doi: 10.1016/j.amepre.2005.06.014.
•   Whitfield R, Cope GF
  Point-of-care test to monitor adherence to anti-tuberculous treatment. Ann Clin Biochem. 2004 Sep;41(Pt 5):411-3. doi: 10.1258/0004563041731637.
•   WHO Multi-Country Study on Women's Health and Domestic Violence: core questionnaire and WHO instrument, version 9
  Geneva, Switzerland: World Health Organization; 2000.
•   WHO Policy on Collaborative TB/HIV Activities: Guidelines for National Programmes and Other Stakeholders
  Geneva: World Health Organization; 2012. Available from http://www.ncbi.nlm.nih.gov/books/NBK131887/
•   Wilson IB, Lee Y, Michaud J, Fowler FJ Jr, Rogers WH
  Validation of a New Three-Item Self-Report Measure for Medication Adherence. AIDS Behav. 2016 Nov;20(11):2700-2708. doi: 10.1007/s10461-016-1406-x.
•   World Health Organization
  Global tuberculosis control 2015. Geneva; WHO; 2015. http://www.who.int/tb/publications/global_report/gtbr15_main_text.pdf. Accessed Jan 20, 2016.
•   World Health Organization
  Guidelines for intensifed tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva; WHO 2010.
•   World Health Organization
  Policy brief: Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: What's new. November 2015. Geneva; WHO 2015.
•   Yirdaw KD, Jerene D, Gashu Z, Edginton ME, Kumar AM, Letamo Y, Feleke B, Teklu AM, Zewdu S, Weiss B, Ruff A
  Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia. PLoS One. 2014 Aug 8;9(8):e104557. doi: 10.1371/journal.pone.0104557. eCollection 2014.

PROvide MIner-friendly SErvices for Integrated TB/HIV Care in Lesotho Study (PROMISE Study)

Details for clinical trial NCT03537872